During the past decade, Marion L Shepard Cancer Center at Vidant Beaufort Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 26 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 12 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marion L Shepard Cancer Center at Vidant Beaufort Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Novartis Pharmaceuticals" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marion L Shepard Cancer Center at Vidant Beaufort Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Marion L Shepard Cancer Center at Vidant Beaufort Hospital" are "Breast Cancer" (12 trials), "Breast Adenocarcinoma" (4 trials), "Recurrent Breast Carcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Marion L Shepard Cancer Center at Vidant Beaufort Hospital" in a lesser frequency.

Most popular intervention types in "Marion L Shepard Cancer Center at Vidant Beaufort Hospital" are "Drug" (50 trials), "Other" (37 trials), "Biological" (16 trials), "Procedure" (12 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Quality-of-Life Assessment" (11 trials), "Paclitaxel" (9 trials), "Biospecimen Collection" (7 trials) and "Computed Tomography" (7 trials). Other intervention names were less common.

The vast majority of trials in "Marion L Shepard Cancer Center at Vidant Beaufort Hospital" are 38 trials for "All" genders, 16 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Marion L Shepard Cancer Center at Vidant Beaufort Hospital". undefined are not yet recruiting, 11 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Marion L Shepard Cancer Center at Vidant Beaufort Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Marion L Shepard Cancer Center at Vidant Beaufort Hospital, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".